Clinical trials are a critical, but challenging, necessity in providing healthcare to patients. They are often expensive, difficult for patients to access, and limited in their cohort diversity. Additionally, there is often a gap in the continuation of care as patients transition from trials back to a standard healthcare setting. This webinar will bring together five industry leaders to provide their perspectives on how digital tools will ease some of the pain points in clinical trials and lead to the improvement in patient care.
Proposed talking points:
Christine Sakdalan is the Vice President of Customer Engagement Strategy and Solutions at Otsuka. She has a proven track record of building new, diverse teams and organizational capabilities, leading high performing teams, delivering high impact business results, driving transformation, developing effective leaders, and building an inclusive culture. Before joining Otsuka, Christine worked at Janssen Pharmaceuticals as the Head of Franchise Strategy and Customer Solutions where she was responsible for the long-term strategy for the Neuroscience portfolio and led various marketing teams including Payer and Market Access, Customer Engagement and Experience, Customer Solutions, Strategic Business Operations, and field based Patient Access Specialists. Throughout her career, she has been a visionary leader who loves transformation and building from the ground up to create positive patient outcomes.
With more than 25 years of diverse experience ranging from industrial engineering to start-ups, Patricia has held senior leadership positions as VP of Sales and previously VP of Marketing at Novo Nordisk and has deep commercial experience in market access. She is recognized for building a successful clinical education business unit from the ground up with over 300+ employees. Her team was recognized as best in class within the industry and held national recognition through NCQA for Program Design. She has deep commercial experience having led multiple leadership roles in Sales leadership, Marketing and Market Access and sat on the Executive Marketing Leadership Team for several years which had oversight to the entire Novo Nordisk US commercial budget.
Dr. Dash is an Associate Professor and preventive cardiologist at Stanford Medical School and is Co-Founder and Chairman of HealthPals, Inc. He earned his MD-PhD from the University of Cincinnati MSTP program, with a focus in cardiovascular pharmacology. Following medicine residency at the University of Washington and a core/chief cardiology fellowship at UCSF, Dr. Dash joined Stanford’s faculty in 2009 and created the nation’s first cardiology clinic dedicated to preventing heart disease in South Asians. Dr. Dash launched Stanford’s first combined medical/lifestyle telemedicine program, CardioClick, that completely virtualized follow up care of SSATHI patients, and which resulted in dramatic improvements in patient engagement, medication adherence, and clinical outcomes.
Michelle has been working in the drug and device development industry for 30 years. As Chief Data Officer at Parexel she presently leads the development of Parexel’s real world data capability, working closely with her colleagues to solve the challenges to the use of real-world data in clinical research, as well as leads Parexel’s enterprise data governance. As CDO, she is focused on Parexel’s culture surrounding its data as its asset and the value to be created from it. As a leader, Michelle is committed to establishing inclusive, invested, innovative teams that transform clinical development for the benefit of patients.
Dr Joy Bhosai, is inspired by innovations that address gaps in access to high-quality care. As an Entrepreneur-in-Residence at Duke, she is the co-founder/CEO of Pluto Health, a company focused on improving patient access and care through a health platform that bridges siloed real world data (RWD) to address gaps in care. She previously served as Chief of Digital Health and Strategy for the Duke Clinical Research Institute. Through previous public health work in Africa and Asia, she developed innovations focused on improving access to health services that were used for clinical trials. Dr. Bhosai received a Masters of Public Health from Yale, an MD with distinction from UCSF, and completed the management and leadership residency program at Duke.
Sian is a senior executive, adviser and former broadcast journalist with 25 years of experience across journalism, government, public health communications, and business. As the long-standing Director General of Communications at the Department of Health (1999-2011), she was professional head for NHS communicators as well as a member of the Departmental and NHS Boards and led the public health marketing programme, including campaigns to tackle childhood obesity, smoking cessation and cancer awareness. Sian was awarded the CB in 2009 for her services to the Department of Health where she worked closely with six secretaries of state and more than 30 ministers over 12 years..
Date: Tuesday, November 2, 2021
Time: 12pm ET / 9am PT
Duration: 1 Hour
Now Available On-Demand